Adenosine NDC 55150-192

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-192Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0192Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-192-01	55150019201	1 VIAL, SINGLE-DOSE in 1 CARTON (55150-192-01) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 2, 2017
55150-192-20	55150019220	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-192-20) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 2, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adenosine
Generic name (nonproprietary): adenosine
Active ingredients: Adenosine — 60 mg/20mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Eugia US LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205331
Marketing start: Nov 2, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Adenosine Receptor Agonists (Mechanism)
Identifiers: Product ID 55150-192_3329ba34-b3ed-4517-8055-38c522dcf0b0SPL ID 3329ba34-b3ed-4517-8055-38c522dcf0b0SPL set ID 61d9b8f6-f93f-46ee-bec2-db8d46999792RxCUI 1654035, 1654040UNII K72T3FS567UPC 0355150193011, 0355150192014
Pharmacologic class: Adenosine Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150019201 followed by a unit qualifier and the quantity

Package 55150-0192-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 5, 2023.

Indications (excerpt from the label)

Adenosine injection, USP is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Adenosine injection USP, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205331

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205331
Product	Strength	Form · route	Labeler	Product NDC
Adenosine	Adenosine 90 mg/30mL	Injection, SolutionIntravenous	Eugia US LLC	55150-193